Genetic subtype differences in neural circuitry of food motivation in Prader-Willi syndrome

International Journal of Obesity

Volumn 33, Issue 2, 2009, Pages 273-283

  Holsen, L M ^a   Zarcone, J R ^b   Chambers, R ^c   Butler, M G ^d   Bittel, D C ^e   Brooks, W M ^c,d   Thompson, T I ^f   Savage, C R ^c,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Brain activity; FMRI; Genetic phenotypes; Hyperphagia; Prader Willi syndrome

Indexed keywords

AMYGDALOID NUCLEUS; ARTICLE; BEHAVIOR; BODY MASS; BODY WEIGHT; CHILD; CHROMOSOME; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; EATING; FEMALE; FOOD INTAKE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENDER; GENE DELETION; GENE DOSAGE; GENETIC ASSOCIATION; GENETIC DIFFERENCE; HUMAN; HYPERPHAGIA; MALE; MEAL; MOTIVATION; NERVE CELL NETWORK; NEUROIMAGING; PHENOTYPE; PRADER WILLI SYNDROME; PREFRONTAL CORTEX; PRESCHOOL CHILD; PRIORITY JOURNAL; SUBICULUM; UNIPARENTAL DISOMY;

APPETITE; BRAIN; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 15; FEMALE; HUMANS; HYPERPHAGIA; MAGNETIC RESONANCE IMAGING; MALE; NERVE NET; PHENOTYPE; PHOTIC STIMULATION; PRADER-WILLI SYNDROME; QUESTIONNAIRES; UNIPARENTAL DISOMY; YOUNG ADULT;

EID: 60249100257     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2008.255     Document Type: Article

References (61)

1. Whittington JE, Holland AJ, Webb T, Butler J, Clarke D, Boer H. Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J Med Genet 2001; 38: 792-798.
2. Butler MG. Prader-Willi Syndrome: current understanding of cause and diagnosis. Am J Med Genet 1990; 35: 319-332.
3. Bittel DC, Butler MG. Prader-Willi syndrome: clinical genetics, cytogenetics and molecular biology. Expert Rev Mol Med 2005; 7: 1-20.
4. Clarke DJ, Boer H. Problem behaviors associated with deletion Prader-Willi, Smith-Magenis, and cri du chat syndromes. Am J Ment Retard 1998; 103: 264-271.
5. Holm VA, Pipes PL. Food and children with Prader-Willi syndrome. Am J Dis Child 1976; 130: 1063-1067.
6. Zipf WB, Bernston GG. Characteristics of abnormal food-intake patterns in children with Prader-Willi syndrome and study of effects of naloxone. Am J Clin Nutr 1987; 46: 277-281.
7. Stevenson DA, Heinemann J, Angulo M, Butler MG, Loker J, Rupe N et al. Gastric rupture and necrosis in Prader-Willi syndrome. J Pediatr Gastroenterol Nutr 2007; 45: 272-274.
8. Butler MG. Management of obesity in Prader-Willi syndrome. Nat Clin Pract Endocrinol Metab 2006; 2: 592-593.
9. Butler MG, Jacobsen D, Smith BK, Donnelly JE. Genetics and obesity: Prader-Willi syndrome, an illustrative example. In: Ling PR (ed). Focus on Obesity Research. Nova Science Publishers, Inc.: Hauppauge, NY, 2005, pp 51-88.
10. Bosio L, Beccaria L, Benzi F, Sanzari A, Chiumello G. Body composition during GH treatment in Prader-Labhart-Willi syndrome. J Pediatr Endocrinol Metab 1999; 12: 351-353.
11. Carrel AL, Myers SE, Whitman BY, Allen DB. Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: a controlled study. J Pediatr 1999; 134: 215-221.
12. Mewborn SK, Milley NL, Fantes JA, Brown RL, Butler MG, Christian SL et al. Break point junction fragments in Prader-Willi and Angelman syndrome (PWS/AS) deletion patients reveal variable breakpoints within large duplicons. Am J Hum Genet 2002; 71: A298.
13. Nicholls RD, Knepper JL. Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annu Rev Genom Hum Genet 2001; 2: 153-175.
14. Ungaro P, Christian SL, Fantes JA, Mutirangura A, Black S, Reynolds J et al. Molecular characterization of four cases of intrachromosomal triplication of chromosome 15q11-q14. Am J Med Genet 2001; 38: 26-34.
15. Butler MG, Fischer W, Kibiryeva N, Bittel DC. Array comparative genomic hybridization (aCGH) analysis in Prader-Willi Syndrome. Am J Med Genet 2008; 146: 854-860.
16. Cassidy SB, Forsythe M, Heeger S, Nicholls RD, Schork N, Benn P et al. Comparison of phenotype between patients with Prader-Willi syndrome due to deletion 15q and uniparental disomy 15. Am J Med Genet 1997; 68: 433-440.
17. Gillessen-Kaesbach G, Robinson W, Lohmann D, Kaya-Westerloh S, Passarge E, Horsthemke B. Genotype-phenotype correlation in a series of 167 deletion and non-deletion patients with Prader-Willi syndrome. Hum Genet 1995; 96: 638-643.
18. Butler MG, Bittel DC, Kibiryeva N, Talebizadeh Z, Thompson T. Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy. Pediatrics 2004; 113: 565-573.
19. Hartley SL, MacLean WE, Butler MG, Zarcone J, Thompson T. Maladaptive behaviors and risk factors among the genetic subtypes of Prader-Willi syndrome. Am J Med Genet 2005; 136: 140-145.
20. Webb T, Whittington J, Clarke D, Boer H, Butler J, Holland A. A study of the influence of different genotypes on the physical and behavioral phenotypes of children and adults ascertained clinically as having PWS. Clin Genet 2002; 62: 273-281.
21. Fox R, Yang GS, Feurer ID, Butler MG, Thompson T. Kinetic form discrimination in Prader-Willi syndrome. J Intell Disabil Res 2001; 45: 317-325.
22. Roof E, Stone W, MacLean W, Feurer ID, Thompson T, Butler MG. Intellectual characteristics of Prader-Willi syndrome: comparison of genetic subtypes. J Intellect Disabil Res 2000; 44: 25-30.
23. Torrado M, Araoz V, Baialardo E, Abraldes K, Mazza C, Krochik G et al. Clinical-etiologic correlation in children with Prader-Willi syndrome (PWS): an intradisciplinary study. Am J Med Genet 2007; 143A: 460-468.
24. Vogels A, De Her M, Descheemaeker MJ, Govers V, Devriendt K, Legius E et al. Psychotic disorders in Prader-Willi syndrome. Am J Med Genet 2004; 127A: 238-243.
25. Zarcone J, Napolitano D, Peterson C, Breidbord J, Ferraioli S, Caruso-Anderson M et al. The relationship between compulsive behaviour and academic achievement across the three genetic subtypes of Prader-Willi syndrome. J Intellect Disabil Res 2007; 51: 478-487.
26. Shapira NA, Lessig MC, He AG, James GA, Driscoll DJ, Liu Y. Satiety dysfunction in Prader-Willi syndrome demonstrated by fMRI. J Neurol Neurosurg Psychiatry 2005; 76: 260-262.
27. Holsen LM, Zarcone JR, Brooks WM, Butler MG, Thompson TI, Ahluwalia JS et al. Neural mechanisms underlying hyperphagia in Prader-Willi syndrome. Obesity 2006; 14: 1028-1037.
28. Hinton EC, Holland AJ, Gellatly MSN, Soni S, Patterson M, Ghatei MA et al. Neural representations of hunger and satiety in Prader-Willi syndrome. Int J Obesity 2006; 30: 313-321.
29. Miller JL, James GJ, Goldstone AP, Couch JA, He G, Driscoll D et al. Enhanced activation of reward mediating prefrontal regions in response to food stimuli in Prader-Willi syndrome. J Neurol Neurosurg Psychiatry 2007; 78: 615-619.
30. Dimitropoulos A, Schultz RT. Food-related neural circuitry in Prader-Willi syndrome: response to high- versus low-calorie foods. J Autism Dev Disord 2008; 38: 1642-1653.
31. Kim SE, Jin D-K, Choo SS, Kim J-H, Hong SD, Paik KH et al. Regional cerebral glucose metabolic abnormality in Prader-Willi syndrome: a 18F-FDG PET study under sedation. J Nucl Med 2006; 47: 1088-1092.
32. 11C]flumazenil. Neuroimage 2004; 22: 22-28.
33. Goldstone AP. Prader-Willi syndrome: advances in genetics, pathophysiology and treatment. Trends Endocrinol Metab 2004; 15: 12-20.
34. Stunkard AJ, Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 1985; 29: 71-83.
35. Gelman N, Gorell JM, Barker PB, Savage RM, Spickler EM, Windham JP et al. MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology 1999; 210: 759-767.
36. LaBar KS, Gitelman DR, Parrish TB, Kim Y, Nobre AC, Mesulam MM. Hunger selectivity modulates corticolimbic activation to food stimuli in humans. Behav Neurosci 2001; 115: 493-500.
37. Talairach J, Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain. Thieme Medical Publishing: New York, 1988.
38. Friston KJ, Holmes AP, Worsley JJ. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapping 1995; 2: 189-210.
39. Holsen LM, Zarcone JR, Thompson TI, Brooks WM, Anderson MF, Ahluwalia JS et al. Neural mechanisms underlying food motivation in children and adolescents. Neuroimage 2005; 27: 669-676.
40. Bittel DC, Kibiryeva N, Butler MG. Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader-Willi syndrome. Pediatrics 2006; 118: 1276-1283.
41. Bittel DC, Kibiryeva N, Sell SM, Strong TV, Butler MG. Whole genome microarray analysis of gene expression in Prader-Willi syndrome. Am J Med Genet 2007; 143: 488-492.
42. Gautier JF, Chen K, Salbe AD, Bandy D, Pratley RE, Heiman M et al. Differential brain responses to satiation in obese and lean men. Diabetes 2000; 49: 838-846.
43. Rothemund Y, Preuschhof C, Bohner G, Bauknecht HC, Klingebiel R, Flor H et al. Differential activation of the dorsal striatum by high-calorie visual food stimuli in obese individuals. Neuroimage 2007; 37: 410-421.
44. Ongur D, Price JL. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb Cortex 2000; 10: 206-219.
45. Ongur D, Ferry AT, Price JL. Architectonic subdivision of the human orbital and medial prefrontal cortex. J Comp Neurol 2003; 460: 425-449.
46. Hinton EC, Holland AJ, Gellatly MSN, Soni S, Owen AM. An investigation into food preferences and the neural basis of food-related incentive motivation in Prader-Willi syndrome. J Intellect Disabil Res 2006; 50: 633-642.
47. Miller EK. The prefrontal cortex and cognitive control. Nat Rev Neurosci 2000; 1: 59-65.
48. DelParigi A, Chen K, Salbe AD, Hill JO, Wing RR, Reiman EM et al. Successful dieters have increased neural activity in cortical areas involved in the control of behavior. Int J Obes 2007; 31: 440-448.
49. Bittel DC, Kibiryeva N, Talebizadeh Z, Butler MG. Microarray analysis of gene/transcript expression in Prader-Willi syndrome: deletion versus UPD. J Med Genet 2003; 40: 568-574.
50. Tobet SA, Henderson RG, Whiting PJ, Sieghart W. Special relationship of gamma-aminobutyric acid to the ventromedial nucleus of the hypothalamus during embryonic development. J Comp Neurol 1999; 405: 88-98.
51. DeLorey TM, Handforth A, Anagnostaras SG, Homanics GE, Minassian BA, Asatourian A et al. Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J Neurosci 1998; 18: 8505-8514.
52. Homanics GE, DeLorey TM, Firestone LL, Quinlan JJ, Handforth A, Harrison NL et al. Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc Natl Acad Sci USA 1997; 94: 4143-4148.
53. Kurita M, Kuwajima T, Nishimura I, Yoshikawa K. Necdin downregulates CDC2 expression to attenuate neuronal apoptosis. J Neurosci 2006; 26: 12003-12013.
54. Kuwajima T, Nishimura I, Yoshikawa K. Necdin promotes GABAergic neuron differentiation in cooperation with Dlx homeodomain proteins. J Neurosci 2006; 26: 5383-5392.
55. Lee S, Walker CL, Wevrick R. Prader-Willi syndrome transcripts are expressed in phenotypically significant regions of the developing mouse brain. Gene Expr Patterns 2003; 3: 599-609.
56. Pagliardini S, Ren J, Wevrick R, Greer JJ. Developmental abnormalities of neuronal structure and function in prenatal mice lacking the Prader-Willi syndrome gene necdin. Am J Pathol 2005; 167: 175-191.
57. Muscatelli F, Abrous DN, Massacrier A, Boccaccio I, Le Moal M, Cau P et al. Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome. Hum Mol Genet 2000; 9: 3101-3110.
58. Bischof JM, Stewart CL, Wevrick R. Inactivation of the mouse Magel2 gene results in growth abnormalities similar to Prader-Willi Syndrome. Hum Mol Genet 2007; 16: 2713-2719.
59. Albrecht U, Sutcliffe JS, Cattanach BM, Beechey CV, Armstrong D, Eichele G et al. Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons. Nat Genet 1997; 17: 75-78.
60. Joseph B, Egli M, Sutcliffe JS, Thompson T. Possible dosage effect of maternally expressed genes on visual recognition memory in Prader-Willi syndrome. Am J Med Genet 2001; 105: 71-75.
61. Soni S, Whittington J, Holland AJ, Webb T, Maina E, Boer H et al. The course and outcome of psychiatric illness in people with Prader-Willi syndrome: implications for management and treatment. J Intellect Disabil Res 2007; 51: 32-42.